Stock Under $10 with 50-100% upside potential - 14 Days FREE!

Vertex Pharmaceuticals (VRTX)

NASDAQ: Health Care

Get a 5-page Ratings Report on (VRTX) now
$78.43 -1.04 | -1.31%
Today's Range: 77.67 - 81.45
VRTX Avg. Daily Volume: 2,561,600
05/22/13 - 4:00 PM ET
  • Latest Dividend: N/A
  • Latest Dividend Yield: N/A
  • Dividend Ex-Date: N/A
  • Price Earnings Ratio: -33.67
  • Price Earnings Comparisons:
    VRTX Sector Avg. S&P 500
    -33.67 0.00 17.70
  • Price Performance History
    (% change):
    3 Mo 1 Yr 3 Yr
    77.31% 26.30% 132.91%
  • GROWTH 12 Mo 3 Yr CAGR
    Revenue 8.30 13.99 1.44
    Net Income -100.00 -0.92 0.00
    EPS -100.00 -0.87 0.00
  • Earnings for VRTX:
    EBITDA 42,367,000
    REVENUE 1.53B
Average Earnings Estimates
Qtr (06/13) Qtr (09/13) FY (12/13) FY (12/14)
Average Estimate $-0.21 $-0.26 $-2.13 $-1.42
Number of Analysts 7 7 10 10
High Estimate $-0.12 $-0.19 $-1.00 $0.15
Low Estimate $-0.32 $-0.38 $-2.56 $-2.69
Prior Year $0.32 $0.00 $0.68 $-2.13
Growth Rate (Year over Year) -164.73% n.a.% -412.79% 33.29%
(VRTX) News

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
TRY IT FREE

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Dividend Stock Advisor
TRY IT FREE
New! $49.95/yr

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREE

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Real Money
TRY IT FREE

24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.

Product Features:
  • Jim Cramer + 20 Wall Street pros
  • Intraday commentary & news
  • Real-time trading forum
  • Actionable trade ideas
Real Money Pro
TRY IT FREE

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass + 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
TRY IT FREE

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
DOW 15,307.17 -80.41 -0.52%
NASDAQ 3,463.30 -38.82 -1.11%
S&P 500 1,655.35 -13.81 -0.83%
US 10 Yr 2.026% +0.082

Brokerage Partners

Advertising Partners

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

We respect your privacy.

Top Rated Stocks Top Rated Funds Top Rated ETFs